BATS BZX Real-Time Price
As of 11:10am ET
| +1.24 / +3.83%|
The 6 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 39.00, with a high estimate of 41.00 and a low estimate of 28.00. The median estimate represents a +16.14% increase from the last price of 33.58.
The current consensus among 6 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.